Physician profile
Fern Gail Fried
NPI 1760422422
$3,603.73
in general payments reported to CMS, 2019-2025
23 companies · $455 in 2025
The $455 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,090 · 2020: $321 · 2021: $287 · 2022: $330 · 2023: $356 · 2024: $765 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $698.65 | 2019-2023 | Xeomin |
| Abbvie INC. | $626.82 | 2019-2025 | |
| Galderma Laboratories, L.P. | $382.54 | 2019-2025 | Nemluvio |
| Janssen Scientific Affairs, LLC | $371.61 | 2019-2021 | |
| Leo Pharma INC. | $256.64 | 2019-2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $134.57 | 2023-2025 | Blu-U |
| Dermavant Sciences, INC. | $125.00 | 2024 | Vtama |
| Genzyme Corporation | $124.85 | 2022-2025 | |
| Ucb, INC. | $123.48 | 2025 | Bimzelx |
| Amgen INC. | $122.04 | 2022 | |
| Incyte Corporation | $116.86 | 2022-2024 | Opzelura |
| Lilly USA, LLC | $111.54 | 2024 | |
| Allergan, INC. | $83.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $77.70 | 2019-2023 | |
| Vyne Pharmaceuticals INC. | $74.13 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $69.95 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $25.16 | 2020 | |
| Revance Therapeutics, INC. | $20.73 | 2024 | Daxxify |
| Helsinn Therapeutics (U.S.), INC. | $15.94 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.04 | 2021 | |
| Mayne Pharma Commercial LLC | $12.50 | 2020 | |
| Prugen, INC. Pharmaceuticals | $11.97 | 2020 | |
| Organon LLC | $2.39 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fern Fried listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.